The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies - Full Text View

The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies (GS-PET-2008)

This study is currently recruiting participants.

Verified by Rabin Medical Center, May 2008

Sponsored by:	Rabin Medical Center
Information provided by:	Rabin Medical Center
ClinicalTrials.gov Identifier:	NCT00706212

Purpose

PET CT is one of the imaging tools that are used for staging of urological malignancies.

C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed ~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Condition
Urological Malignancies

MedlinePlus related topics: Cancer

Drug Information available for: Choline Choline bitartrate Choline chloride Choline dihydrogen citrate Choline salicylate

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis

Further study details as provided by Rabin Medical Center:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	60
Study Start Date:	June 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Rabin Medical center Urological oncology patients

Criteria

Inclusion Criteria:

Patients older then 18 years of age
Full consciousness and awareness
suspected to suffer from urological malignancy and a candidate for a surgical procedur

Exclusion Criteria:

known secondary malignancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00706212

Contacts

Contact: Shay Golan, MD

972-50-744-7573

shaygo1@yahoo.com

Locations

Israel
Rabin Medical Center, Beilinson hospital	Recruiting
Petach Tikva, Israel, 49100
Principal Investigator: Shay Golan, MD

Sponsors and Collaborators

Rabin Medical Center

More Information

Responsible Party:	Rabin Medical Center, Urology department ( Dr. Golan Shay )
Study ID Numbers:	GS-PET-2008
Study First Received:	June 26, 2008
Last Updated:	June 26, 2008
ClinicalTrials.gov Identifier:	NCT00706212
Health Authority:	Israel: Ethics Commission; Israel: Israeli Health Ministry Pharmaceutical Administration

Study placed in the following topic categories:

Choline

Additional relevant MeSH terms:

Neoplasms

ClinicalTrials.gov processed this record on January 16, 2009